February 28, 2006 - The inability to perform sexually can have a significant negative psychosocial impact on a man's overall health including depression, anxiety, and low self-esteem. New research ...
TORONTO--(BUSINESS WIRE)--Vasomune Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced today the first subjects have been dosed in a Phase 1 study of AV-001 in healthy subjects.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results